Recently, an increasing number of researchers have found that USP11 is involved in the occurrence and development of multiple cancers, such as colorectal, breast, hepatocellular, and ovarian cancers, implying that USP11 is a potential therapeutic target for a variety of cancers. Here, USP11 is linked to ovarian carcinoma.